{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T14:06:49Z","timestamp":1763388409339},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,1,29]],"date-time":"2009-01-29T00:00:00Z","timestamp":1233187200000},"content-version":"vor","delay-in-days":2919,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item>\n<jats:p>The pharmacological characteristics of muscarinic receptors mediating contraction of dog isolated ciliary muscle were determined and compared to those mediating contraction of dog urinary bladder smooth muscle.<\/jats:p>\n<\/jats:list-item>\n<jats:list-item>\n<jats:p>(+)\u2010Cis\u2010dioxolane induced concentration\u2010dependent contractions of ciliary muscle (pEC<jats:sub>50<\/jats:sub>=7.18\u00b10.07, E<jats:sub>max<\/jats:sub>=453\u00b164\u2003mg, <jats:italic>n<\/jats:italic>=19) and urinary bladder isolated smooth muscle (pEC<jats:sub>50<\/jats:sub>=6.55\u00b10.07, E<jats:sub>max<\/jats:sub>=11\u00b11\u2003g, <jats:italic>n<\/jats:italic>=19). These responses were antagonized by several muscarinic receptor antagonists (p<jats:italic>K<\/jats:italic><jats:sub>b<\/jats:sub> values for the ciliary muscle and the bladder smooth muscle, respectively): atropine (8.25\u00b10.14 and 9.21\u00b10.09), pirenzepine (6.31\u00b10.13 and 6.70\u00b10.25), tolterodine (7.97\u00b10.14 and 8.68\u00b10.12), oxybutynin (7.40\u00b10.08 and 7.88\u00b10.12), zamifenacin (6.46\u00b10.19 and 7.69\u00b10.11), S\u2010secoverine (6.66\u00b10.14 and 8.13\u00b10.07), AQ\u2010RA 741 (6.16\u00b10.15 and 7.08\u00b10.23), p\u2010F\u2010HHSiD (7.10\u00b10.27 and 7.35\u00b10.07) and responses were not antagonized by PD 102807 (up to 100\u2003n<jats:sc>M<\/jats:sc>).<\/jats:p>\n<\/jats:list-item>\n<jats:list-item>\n<jats:p>In urinary bladder smooth muscle, the profile of antagonist p<jats:italic>K<\/jats:italic><jats:sub>B<\/jats:sub> values correlated significantly with p<jats:italic>K<\/jats:italic><jats:sub>i<\/jats:sub> values at human recombinant m<jats:sub>3<\/jats:sub> muscarinic receptors, suggesting that M<jats:sub>3<\/jats:sub> muscarinic receptors mediated the response. In the ciliary muscle, a significant (<jats:italic>P<\/jats:italic>&lt;0.01) correlation was obtained with human recombinant m<jats:sub>3<\/jats:sub> and m<jats:sub>5<\/jats:sub> receptors.<\/jats:p>\n<\/jats:list-item>\n<jats:list-item>\n<jats:p>Darifenacin displayed insurmountable antagonism at receptors in the bladder. At receptors in the ciliary muscle, it exhibited two phases of antagonism, comprising an initial low affinity (p<jats:italic>K<\/jats:italic><jats:sub>B<\/jats:sub>&lt;6) component and a high affinity phase (p<jats:italic>K<\/jats:italic><jats:sub>B<\/jats:sub>&gt;8).<\/jats:p>\n<\/jats:list-item>\n<jats:list-item>\n<jats:p>The role of pigmentation in the atypical behaviour of darifenacin was examined. In blue coloured eyes, darifenacin produced apparent surmountable, competitive antagonism of the responses to (+)\u2010cis\u2010dioxolane (p<jats:italic>K<\/jats:italic><jats:sub>B<\/jats:sub>=8.76\u00b10.07). The antagonist profile obtained in this tissue suggested the involvement of a site which has the pharmacological attributes of the M<jats:sub>5<\/jats:sub> receptor.<\/jats:p>\n<\/jats:list-item>\n<jats:list-item>\n<jats:p>We suggest that the dog urinary bladder contracts in response to M<jats:sub>3<\/jats:sub> muscarinic receptor activation. Contraction of the brown\u2010eyed dog ciliary muscle is more complex and may include involvement of at least two receptors, possibly the M<jats:sub>5<\/jats:sub> and M<jats:sub>3<\/jats:sub> receptor, whereas blue\u2010eyed dog ciliary muscle may involve a single population of M<jats:sub>5<\/jats:sub> muscarinic receptors.<\/jats:p>\n<\/jats:list-item>\n<\/jats:list>\n<\/jats:p><jats:p><jats:italic>British Journal of Pharmacology<\/jats:italic> (2001) <jats:bold>132<\/jats:bold>, 835\u2013842; doi:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"doi\" xlink:href=\"10.1038\/sj.bjp.0703901\">10.1038\/sj.bjp.0703901<\/jats:ext-link><\/jats:p>","DOI":"10.1038\/sj.bjp.0703901","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T21:10:46Z","timestamp":1106946646000},"page":"835-842","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle"],"prefix":"10.1111","volume":"132","author":[{"given":"A","family":"Choppin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Eglen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00512382"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1992.8.35"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00164573"},{"key":"e_1_2_6_5_1","first-page":"206P","article-title":"Pharmacological characterisation of muscarinic receptors in feline and human isolated ciliary smooth muscle","volume":"129","author":"CHOPPIN A.","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701920"},{"key":"e_1_2_6_7_1","first-page":"93P","article-title":"Pharmacological characterisation of muscarinic receptors in dog ciliary smooth muscle","volume":"126","author":"CHOPPIN A.","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_8_1","first-page":"33P","article-title":"S\u2010secoverine: a defining ligand in muscarinic M5 receptors characterization","volume":"128","author":"CHOPPIN A.","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_9_1","first-page":"90P","article-title":"Role of pigmentation in the atypical behaviour of darifenacin in dog ciliary smooth muscle","volume":"128","author":"CHOPPIN A.","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_10_1","volume-title":"Introduction to statistical analysis","author":"DIXON W.J.","year":"1983"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90081-Z"},{"key":"e_1_2_6_12_1","first-page":"727","article-title":"Antagonist binding profiles of five cloned human muscarinic receptor subtypes","volume":"256","author":"D\u00d6RJE F.","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_13_1","first-page":"63P","article-title":"Characterization of the interaction of tolterodine at muscarinic receptor subtypes in vitro and in vivo","volume":"120","author":"EGLEN R.M.","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_14_1","first-page":"531","article-title":"Muscarinic receptor subtypes and smooth muscle function","volume":"48","author":"EGLEN R.M.","year":"1996","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703276"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)93786-E"},{"key":"e_1_2_6_17_1","first-page":"611","article-title":"Different muscarinic receptors mediate the prejunctional inhibition of [3H]\u2010noradrenaline release in rat or guinea\u2010pig iris and the contraction of the rabbit iris sphincter muscle","volume":"345","author":"FUDER H.","year":"1989","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"e_1_2_6_18_1","first-page":"283","volume-title":"Catecholamines, Handbook of Experimental Pharmacology","author":"FURCHGOTT R.F.","year":"1972"},{"key":"e_1_2_6_19_1","first-page":"62P","article-title":"Comparison of muscarinic receptor subtypes in the sheep ciliary muscle and iris sphincter using a radioligand binding aproach","volume":"125","author":"GERMAN E.J.","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1999.15.257"},{"key":"e_1_2_6_21_1","first-page":"1434","article-title":"Muscarinic receptor subtypes in human iris\u2010ciliary body measured by immunoprecipitation","volume":"38","author":"GIL D.W.","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701048"},{"key":"e_1_2_6_23_1","first-page":"590","article-title":"M3\u2010muscarinic receptor subtype predominates in the bovine iris sphincter smooth muscle and ciliary processees","volume":"31","author":"HONKANEN R.E.","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(86)90146-7"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb15065.x"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)90470-8"},{"key":"e_1_2_6_27_1","volume-title":"Manual of histologic staining methods of the Armed Forces Institute of Pathology","author":"LUNA L.G.","year":"1968"},{"key":"e_1_2_6_28_1","first-page":"139P","article-title":"Characterisation and comparison of muscarinic receptors in the dog ciliary muscle with ileum","volume":"115","author":"MCINTYRE P.","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_29_1","first-page":"45P","article-title":"Characterization of functional muscarinic receptors in human bladder","volume":"119","author":"NEWGREEN D.T.","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_6_30_1","first-page":"34","article-title":"Tolterodine is not subtype (m1\u2010m5) selective but exhibits functional bladder selectivity in vivo","volume":"15","author":"NILVEBRANT L.","year":"1996","journal-title":"Neurourol. Urodyn."},{"key":"e_1_2_6_31_1","first-page":"1","article-title":"Pharmacological estimation of drug\u2010receptor dissociation constants. Statistical evaluation. I. Agonists","volume":"177","author":"PARKER R.B.","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_32_1","first-page":"79","article-title":"Iris pigmentation and atropine mydriasis","volume":"197","author":"SALAZAR M.","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.3109\/10799899709036602"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-8673.1995.tb00410.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(95)00221-6"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00021-J"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1993.1052"},{"key":"e_1_2_6_38_1","first-page":"1645","article-title":"Expression of muscarinic receptor subtype mRNa in the human ciliary muscle","volume":"36","author":"ZHANG X.","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0703901","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1038%2Fsj.bjp.0703901","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1038\/sj.bjp.0703901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T06:48:48Z","timestamp":1695883728000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1038\/sj.bjp.0703901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1038\/sj.bjp.0703901"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjp.0703901","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]},"assertion":[{"value":"2009-01-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}